Option Care Health Pandemic Management Plan
By: Option Care Health
March 11, 2020
- As the nation’s largest infusion provider, we are uniquely positioned to treat patients in the safe environment of their own homes and our alternate infusion suites (AIS), which reduces their exposure to further risk in more public settings.
- We’ve always had an Infectious Disease Prevention Plan, which calls for Personal Protective Equipment (PPE) and education of our staff and patients. In light of the coronavirus outbreak, we are actively monitoring CDC guidelines and working with Infectious Disease experts and updating our plans, policies and guidelines as appropriate. We continue to accept and service referrals to care for patients.
- In the event of an employee exposure, including travel to countries that are determined by the CDC to be “Widespread Sustained (ongoing) Transmission,” we have asked employees to please alert Human Resources so that we can determine a go forward plan that may include staying home or working from home for at least 14 days upon their exposure or return from travel.
- Option Care Health 与我们的传染病专家合作，根据美国疾病控制与预防中心的指导方针，目前正在对所有新患者和现有患者进行面诊前的筛查。对于认定为处于风险中的患者（由于旅行或已知接触），注册护士将与患者和处方医生一起跟进后续的工作。
- We are providing updated education and information to our teams on an almost daily basis.
- Our Supply Chain team is working with our vendors to make sure that Option Care Health has adequate supplies available for both patient care and PPE for our employees to maintain continuity of care.
You might also be interested in:
Option Care Health Collaborating with Leading Health Systems to Accelerate Patient Discharges During the COVID-19 Pandemic
Infusion Care Provider’s Clinical Expertise and National Scale Ensure High-Quality Care in a Lower-Risk Setting BANNOCKBURN, Ill., April 14, 2020 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, is on the frontlines of the COVID-19 pandemic, working in collaboration with our […]
Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge
Creates a Leading Independent Provider of Home and Alternate Site Infusion Services with Deep Clinical Expertise and Broad Therapy Portfolio Enhanced Scale and Improved Financial Profile Expected to Enable Growth in Attractive and Growing Segment of U.S. Healthcare Market BioScrip to Issue New Shares to Option Care’s Shareholder, Which Will Own Approximately 80% of Combined […]